T1	Entity 159 173	p53 regulation
T2	Entity 204 213	p53 locus
T3	Entity 220 244	homologous recombination
T4	Entity 248 256	ES cells
T5	Entity 385 394	p53 locus
T6	KeyEntity 421 473	Recombinase-Mediated Cassette Exchange (RMCE) method
T7	Entity 519 527	ES cells
T8	KeyEntity 637 688	Somatic cells to Accelerate Phenotyping (RMCE-ASAP)
T9	Entity 734 743	p53 locus
T10	Entity 779 790	fibroblasts
T11	KeyEntity 871 880	RMCE-ASAP
T12	Entity 1015 1023	ES cells
T13	KeyEntity 1095 1104	RMCE-ASAP
R1	is_part_of Arg1:T2 Arg2:T4	
T14	Entity 827 845	recessive mutation
T15	Entity 890 936	inverted heterologous recombinase target sites
T16	Entity 940 974	positive/negative selection marker
T17	Entity 994 1011	germline capacity
T18	Entity 1033 1056	power of mouse genetics
T19	KeyEntity 0 9	RMCE-ASAP
T20	Entity 39 41	ES
T21	Entity 46 59	somatic cells
T22	Entity 74 92	phenotype analyses
T23	Entity 1145 1148	p53
T24	Entity 1308 1319	p53 mutants
T25	Entity 1264 1288	transfection of plasmids
T26	Entity 1360 1363	p53
T27	Entity 1456 1465;1473 1482	mutations p53 locus
T28	Entity 1489 1513	homologous recombination
T29	Entity 1517 1536	embryonic stem (ES)
T30	Entity 1671 1690	endogenous promoter
T31	Entity 2053 2077	homologous recombination
T32	Entity 2081 2089	ES cells
T33	Entity 2171 2195	homologous recombination
T34	Entity 2216 2229	low frequency
T35	Entity 28921 28929	ES cells
T36	Entity 29020 29044	homologous recombination
T37	Entity 29049 29053	MEFs
T38	KeyEntity 27444 27448	RMCE
T39	Entity 27452 27456	MEFs
T40	KeyEntity 27462 27466	RMCE
T41	Entity 26581 26602	Germline transmission
T42	Entity 26610 26630	p53 RMCE-ready locus
T43	KeyEntity 26632 26650	p53RMCE/+ ES cells
T44	Entity 26670 26681	blastocysts
T45	Entity 26694 26707	chimeric mice
R2	participates_in Arg1:T44 Arg2:T45	
R3	participates_in Arg1:T43 Arg2:T45	
T46	KeyEntity 24322 24326	RMCE
T47	Entity 24330 24338	ES cells
T48	KeyEntity 24344 24348	RMCE
T49	Entity 24376 24392	exchange plasmid
T50	Entity 23399 23407	ES cells
T51	Entity 23415 23435	p53 RMCE-ready locus
T52	Entity 23441 23449	p53 gene
T53	KeyEntity 21991 22000	RMCE-ASAP
T54	Entity 22008 22032	homologous recombination
T55	Entity 22309 22328	RMCE-ready ES cells
T56	KeyEntity 22540 22549	RMCE-ASAP
T57	KeyEntity 14189 14198	RMCE-ASAP
T58	Entity 14261 14274	floxed allele
T59	Entity 14278 14286	ES cells
R4	is_part_of Arg1:T58 Arg2:T59	
T60	Entity 14572 14582;14586 14590	efficiency RMCE
T61	Entity 14594 14602	ES cells
T62	Entity 14643 14646	p53
T63	Entity 14656 14659	GFP
T64	Entity 14688 14691	p53
T65	Entity 2233 2241	ES cells
R5	is_part_of Arg1:T28 Arg2:T29	
T66	Entity 1745 1769	spatio-temporal profiles
T67	Entity 1701 1732	physiological expression levels
T68	Entity 1831 1842	p53 mutants
T69	Entity 2011 2017;2021 2035	models p53 regulation
T70	Entity 2484 2496	homozygosity
T71	Entity 2767 2770	p53
T72	Entity 2934 2945	fibroblasts
T73	Entity 2990 2996	siRNAs
T74	Entity 3000 3011	fibroblasts
R6	is_part_of Arg1:T73 Arg2:T74	
T75	Entity 3060 3075	gene knock-outs
T76	Entity 3115 3143	disease-associated mutations
T77	Entity 3164 3180	subtle mutations
R7	participates_in Arg1:T77 Arg2:T76	
T78	Entity 3272 3296	homologous recombination
T79	Entity 3257 3268	fibroblasts
T80	Entity 3238 3253	point mutations
R8	is_part_of Arg1:T80 Arg2:T79	
T81	Entity 3310 3321	inefficient
R9	other_relation Arg1:T81 Arg2:T80	
#1	AnnotatorNotes R9	attribute
T82	Entity 3495 3504	p53 locus
T83	Entity 3513 3521	ES cells
T84	Entity 3526 3537	fibroblasts
T85	KeyEntity 3539 3584	Recombinase-Mediated Cassette Exchange (RMCE)
T86	Entity 3673 3689	gene of interest
T87	Entity 3713 3731	selection cassette
T88	Entity 3743 3767	recombinase target sites
T89	Entity 3774 3784	loxP sites
T90	Entity 3789 3804	Cre recombinase
T91	Entity 3818 3832	‘floxed’ locus
T92	Entity 3841 3867	Cre-mediated recombination
T93	Entity 3944 3961	resident sequence
T94	KeyEntity 4045 4049	RMCE
T95	KeyEntity 5024 5040	RMCE experiments
T96	Entity 5080 5098	somatic cell lines
R10	is_subclass_of Arg1:T89 Arg2:T88	
R11	is_part_of Arg1:T89 Arg2:T90	
R12	other_relation Arg1:T92 Arg2:T93	
#2	AnnotatorNotes R12	removes
T97	Entity 4157 4176	repeated loxP sites
T98	Entity 4250 4260	loxP sites
T99	Entity 4359 4386	ntramolecular recombination
T100	KeyEntity 4395 4399	RMCE
T101	Entity 4598 4613	endogenous gene
T102	KeyEntity 4718 4730	optimal RMCE
T103	Entity 4744 4776	inverted heterologous loxP sites
R13	participates_in Arg1:T103 Arg2:T102	
T104	Entity 4855 4874	expression cassette
T105	Entity 4889 4907	positive selection
R14	participates_in Arg1:T105 Arg2:T104	
T106	Entity 4953 4971	negative selection
R15	participates_in Arg1:T106 Arg2:T104	
R16	participates_in Arg1:T104 Arg2:T102	
T107	KeyEntity 5136 5140	RMCE
T108	Entity 5144 5152	ES cells
T109	KeyEntity 5181 5185	RMCE
T110	Entity 5214 5231	selectable marker
T111	KeyEntity 5363 5402	Hygromycin–Thymidine Kinase fusion gene
T112	KeyEntity 5459 5463	RMCE
T113	Entity 5428 5455	positive/negative selection
T114	Entity 5474 5489	mouse sterility
T115	Entity 5534 5542	ES cells
R17	participates_in Arg1:T111 Arg2:T113	
R18	is_part_of Arg1:T113 Arg2:T112	
T116	KeyEntity 5554 5567	RMCE strategy
T117	Entity 5615 5647	inverted heterologous loxP sites
T118	Entity 5651 5685	positive/negative selection marker
T119	Entity 5705 5722	germline capacity
T120	Entity 5726 5734	ES cells
T121	Entity 5744 5767	power of mouse genetics
T122	Entity 5858 5879	marker-free mutations
T123	Entity 5887 5896	p53 locus
T124	Entity 5900 5908	ES cells
T125	Entity 5987 6033	Somatic cells to Accelerate Phenotyping (ASAP)
T126	KeyEntity 6081 6090	RMCE-ASAP
R19	participates_in Arg1:T117 Arg2:T116	
R20	participates_in Arg1:T118 Arg2:T116	
R21	participates_in Arg1:T121 Arg2:T116	
T127	Entity 5780 5799	phenotypic analyses
R22	is_part_of Arg1:T123 Arg2:T124	
R23	is_part_of Arg1:T122 Arg2:T123	
T128	KeyEntity 6714 6718	RMCE
T129	KeyEntity 6751 6755	RMCE
T130	Entity 7810 7817	plasmid
T131	Entity 7833 7839;7847 7866;7874 7882	region homology downstream p53 gene
T132	Entity 7891 7899	DTA gene
R24	is_part_of Arg1:T131 Arg2:T130	
R25	is_part_of Arg1:T132 Arg2:T130	
T133	Entity 8643 8655	Plasmid Flox
T134	Entity 8708 8728	restriction analysis
T135	Entity 8782 8788;8793 8813	verify p53 coding sequences
T136	Entity 8782 8788;8819 8840	verify exon–intron junctions
T137	Entity 8782 8788;8849 8872;8877 8887	verify sequences at and around loxP sites
T138	Entity 8962 8984	p53-GFP fusion protein
T139	Entity 9037 9046	p53 locus
T140	Entity 9787 9810	p53-GFP fusion fragment
T141	KeyEntity 10327 10339	Flox plasmid
T142	Entity 11465 11485	Targeting/genotyping
T143	KeyEntity 11493 11509	RMCE-ready locus
T144	KeyEntity 11757 11761	RMCE
T145	Entity 11804 11812	ES cells
T146	KeyEntity 12242 12246	RMCE
T147	Entity 14946 14970;15034 15038	ES cell clones resistant FIAU
T148	Entity 15081 15084	PCR
T149	Entity 15089 15102	Southern blot
T150	Entity 15172 15192	high RMCE efficiency
T151	KeyEntity 15200 15204	RMCE
T152	Entity 15235 15252	no aberrant bands
T153	Entity 15270 15273	PCR
T154	Entity 15278 15292	Southern blots
R26	other_relation Arg1:T152 Arg2:T153	
#3	AnnotatorNotes R26	attribute
R27	other_relation Arg1:T152 Arg2:T154	
#4	AnnotatorNotes R27	attribute
T155	Entity 15306 15324	p53+/GFP ES clones
T156	Entity 15478 15484;15488 15491;15495 15498	fusion GFP p53
T157	Entity 15518 15531	p53 stability
T158	Entity 15714 15719	p53WT
T159	Entity 15724 15730	p53GFP
T160	Entity 15750 15770	adriamycin treatment
T161	Entity 15801 15816	p53+/GFP clones
T162	Entity 15836 15847	blastocysts
T163	Entity 15867 15890	pseudo-pregnant females
R28	is_part_of Arg1:T161 Arg2:T162	
T164	Entity 15987 15998	p53 pathway
T165	Entity 16032 16034;16047 16052	ES cells
T166	Entity 16039 16052	somatic cells
T167	Entity 16054 16062	ES cells
T168	Entity 16082 16097	high p53 levels
T169	Entity 16102 16106;16111 16134	lack p53-mediated DNA damage
R29	other_relation Arg1:T168 Arg2:T167	
#5	AnnotatorNotes R29	attribute
R30	other_relation Arg1:T169 Arg2:T167	
#6	AnnotatorNotes R30	at
T170	Entity 16215 16261	p53 levels decrease during mouse embryogenesis
T171	Entity 16353 16364;16368 16374	high levels p53GFP
T172	Entity 16382 16390	ES cells
R31	is_part_of Arg1:T171 Arg2:T172	
T173	Entity 16411 16412	c
R32	is_part_of Arg1:T172 Arg2:T173	
T174	Entity 16428 16466	prevented normal embryonic development
T175	KeyEntity 16586 16590	RMCE
T176	Entity 16598 16613	p53 fusion gene
T177	Entity 16627 16656;16670 16675	p53 proline-rich domain (PRD) p53ΔP
T178	Entity 16738 16746;16751 16790	deleting proline-rich domain decreases stability
T179	Entity 16795 16827	compromises DNA-damage responses
T180	Entity 16875 16893	hypomorphic mutant
T181	KeyEntity 16936 16940	RMCE
T182	Entity 16948 16976	p53ΔPGFP replacement plasmid
T183	Entity 17006 17019	western blots
T184	Entity 17090 17109	p53+/ΔPGFP ES cells
T185	Entity 17140 17152	PRD deletion
T186	Entity 17169 17192	lower expression levels
T187	Entity 17194 17202	p53ΔPGFP
R33	other_relation Arg1:T186 Arg2:T185	
#7	AnnotatorNotes R33	associated
T188	Entity 17302 17321	p53+/ΔPGFP ES cells
T189	Entity 17337 17350	chimeric mice
T190	Entity 17410 17435	p53+/ΔPGFP ES cell clones
T191	Entity 17455 17466	blastocysts
R34	is_part_of Arg1:T190 Arg2:T191	
T192	Entity 17514 17531	Heterozygote pups
T193	Entity 17630 17646	marker-free RMCE
T194	Entity 17668 17676	ES cells
T195	Entity 17688 17709	germline transmission
T196	KeyEntity 17789 17793	RMCE
T197	Entity 17844 17854	p53 allele
T198	Entity 17858 17871	somatic cells
T199	Entity 17820 17836	target mutations
R35	is_part_of Arg1:T199 Arg2:T197	
R36	is_part_of Arg1:T197 Arg2:T198	
T200	KeyEntity 17919 17949	RMCE-ready p53 locus (p53RMCE)
T201	Entity 17995 18037	mating p53RMCE/+ chimeras with p53+/− mice
T202	Entity 18096 18110	p53RMCE/− MEFs
T203	KeyEntity 18136 18140	RMCE
T204	Entity 18148 18157	p53 locus
T205	Entity 18161 18174	somatic cells
T206	Entity 18195 18207	RMCE in MEFs
T207	Entity 18211 18241	electroporating p53RMCE/− MEFs
T208	Entity 18249 18271	Cre-expression plasmid
T209	Entity 18280 18294	p53GFP plasmid
T210	Entity 18323 18327	FIAU
T211	Entity 18331 18342	ganciclovir
T212	Entity 18425 18441	RMCE with p53GFP
T213	Entity 18445 18453	ES cells
R37	is_part_of Arg1:T212 Arg2:T213	
T214	Entity 18466 18472;18476 18485;18489 18500	p53GFP expressed high levels
T215	Entity 18543 18554	p53 pathway
T216	Entity 18613 18621	ES cells
T217	Entity 20641 20663	improved RMCE approach
T218	Entity 20677 20706	efficient allele modification
T219	Entity 20710 20718	ES cells
T220	Entity 20731 20735	mice
T221	Entity 20743 20760	heterozygous MEFs
T222	Entity 20764 20794	accelerate phenotypic analyses
T223	KeyEntity 20811 20820	RMCE-ASAP
T224	Entity 20853 20885	inverted heterologous loxP sites
T225	Entity 20889 20923	positive/negative selection marker
T226	Entity 21002 21033;21041 21057	existence of a knock-out allele gene of interest
T227	Entity 20943 20960;20964 20972	germline capacity ES cells
T228	KeyEntity 21093 21102	RMCE-ASAP
T229	Entity 21151 21166	mammalian genes
T230	KeyEntity 21259 21268	RMCE-ASAP
T231	Entity 21295 21318	fibroblastic cell lines
T232	KeyEntity 19700 19704	RMCE
T233	Entity 19708 19722	p53RMCE/− MEFs
T234	Entity 19732 19750	p53ΔPGFP construct
T235	Entity 19752 19776	p53ΔPGFP-expressing MEFs
T236	Entity 19850 19869	ES cell experiments
T237	Entity 19883 19899	p53ΔPGFP protein
T238	Entity 19908 19931	lower levels than p53WT
T239	Entity 19961 19974	p53ΔP/ΔP MEFs
T240	Entity 19979 19985;19989 20021	unable arrest cycling after irradiation
T241	Entity 20051 20068;20074 20097	irradiation doses arrested p53RMCE/− MEFs
T242	Entity 20174 20200	not arrest p53ΔPGFP/− MEFs
T243	Entity 20244 20262	RMCE-ASAP reaction
T244	Entity 20292 20301;20307 20326	detection recessive phenotype
T245	Entity 20366 20385	proline rich domain
T246	Entity 20395 20410	less active p53
T247	Entity 20416 20443	impaired cell cycle control
T248	Entity 20470 20491	GFP C-terminal fusion
T249	Entity 20515 20529	p53 regulation
T250	Entity 18659 18670;18674 18680	high levels p53GFP
T251	Entity 18703 18711	ES cells
T252	Entity 18716 18729	toxic to MEFs
T253	Entity 18739 18743	MEFs
T254	KeyEntity 18756 18760	RMCE
T255	Entity 18823 18837	p53RMCE/− MEFs
T256	Entity 18843 18857;18867 18895	electroporated p53GFP replacement construct
T257	Entity 18914 18936	Cre-expression plasmid
T258	Entity 19150 19154	FIAU
T259	Entity 19158 19169	ganciclovir
T260	Entity 19206 19223	effects of p53GFP
T261	Entity 19275 19297	Cre expression plasmid
T262	KeyEntity 19362 19366	RMCE
T263	Entity 19420 19442	‘fried-egg’ appearance
T264	KeyEntity 19588 19592	RMCE
T265	Entity 19610 19632	p53GFP-expressing MEFs
T266	Entity 19643 19679	die rapidly owing to p53GFP toxicity
